Is California Resources (CRC) Stock Outpacing Its Oils-Energy Peers This Year?
Here is how California Resources Corporation (CRC) and ConocoPhillips (COP) have performed compared to their sector so far this year.
CRC - California Resources Corporation
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$70.83
DETAILS
HIGH:
$84.00
LOW:
$56.00
MEDIAN:
$71.00
CONSENSUS:
$70.83
UPSIDE:
14.17%
Stock News
California Resources Q1 Earnings Beat on Strong Oil Prices
CRC beat Q1 adjusted EPS and revenues on strong oil pricing, even as a massive derivative mark-to-market loss pushed GAAP results into the red.
California Resources Q1 Earnings Call Highlights
California Resources NYSE: CRC reported a stronger-than-expected first quarter and raised its 2026 outlook, citing higher oil prices, improved capital efficiency, accelerated drilling plans and additional cost savings from its Berry merger.
CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update
- Positive data announced from Phase 1 Dose Expansion Study of varsetatug masetecan (“Varseta-M”) EpCAM PROBODY® ADC in Patients with Advanced Colorectal Cancer (CRC) - - Enrollment of 40 patients in Varseta-M Dose Optimization completed; data update expected in 2H 2026 to inform monotherapy dose selection and potential registrational trial in late line CRC - - Varseta-M Phase 1 study evaluating combination with bevacizumab is ongoing with initial data expected by 1H 2027; Phase 1/2 Varseta-M chemotherapy combination study to be initiated in 2H 2026 - - Initiation of Phase 1 expansion cohort(s) in non-CRC indications planned for 2H 2026 - - Company to host conference call today at 5 p.m. ET / 2 p.m.
California Resources Corporation (CRC) Q1 2026 Earnings Call Transcript
California Resources Corporation (CRC) Q1 2026 Earnings Call Transcript
California Resources Corporation (CRC) Q1 Earnings and Revenues Top Estimates
California Resources Corporation (CRC) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.83 per share. This compares to earnings of $1.07 per share a year ago.
California Resources Corporation Reports First Quarter 2026 Financial and Operating Results
Increasing Second Half 2026 Activity to Accelerate Development of Long Duration Oil Inventory Raising 2026E Adjusted EBITDAX Guidance by 42% Driven by Strong Oil Prices, Increased Target Synergies and Expected Operating Efficiencies LONG BEACH, Calif. , May 05, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (CRC) today reported its financial and operating results for the first quarter of 2026.
California Resources Corporation Reports First Quarter 2026 Financial and Operating Results
Increasing Second Half 2026 Activity to Accelerate Development of Long Duration Oil Inventory Raising 2026E Adjusted EBITDAX Guidance by 42% Driven by Strong Oil Prices, Increased Target Synergies and Expected Operating Efficiencies LONG BEACH, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) (CRC) today reported its financial and operating results for the first quarter of 2026.
Carbon TerraVault Provides First Quarter 2026 Update
LONG BEACH, Calif., May 05, 2026 (GLOBE NEWSWIRE) -- Carbon TerraVault Holdings, LLC (CTV), a carbon management subsidiary of California Resources Corporation (NYSE: CRC), today provided a first quarter 2026 update on its financial and operating results.
Permian Resources (PR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Permian Resources (PR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Earnings Preview: California Resources Corporation (CRC) Q1 Earnings Expected to Decline
California Resources (CRC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Should First Trust Mid Cap Core AlphaDEX ETF (FNX) Be on Your Investing Radar?
The First Trust Mid Cap Core AlphaDEX ETF (FNX) was launched on May 8, 2007, and is a passively managed exchange traded fund designed to offer broad exposure to the Mid Cap Blend segment of the US equity market.
California Resources (NYSE:CRC) Shares Down 7.9% – Time to Sell?
California Resources Corporation (NYSE: CRC - Get Free Report)'s share price dropped 7.9% on Friday. The company traded as low as $62.33 and last traded at $61.57. Approximately 55,557 shares traded hands during mid-day trading, a decline of 94% from the average daily volume of 971,280 shares. The stock had previously closed at $66.87. Analysts
A Look at California Resources Corp (CRC) After 6.2% Decline -- GF Value $51.27 vs Price $62.74
On April 17, 2026, California Resources Corp (CRC) shares fell 6.2% to a current price of $62.74. The stock has experienced a 52-week range of $33.85 to $71.98,
Bank of America Still Loves 4 Dividend Paying Energy Stocks Even After Oil Plunged
While the two-week ceasefire came as a relief to many, especially after President Trump had ramped up the rhetoric, the reality is that while boats can move through the Strait of Hormuz, Bank of America reported that a stunning 11 million barrels per day of production remains shut in.
SG Americas Securities LLC Raises Holdings in California Resources Corporation $CRC
SG Americas Securities LLC boosted its stake in shares of California Resources Corporation (NYSE: CRC) by 107.6% in the undefined quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 28,300 shares of the oil and gas producer's stock after acquiring an additional 14,665 shares during
Buy 3 Sales Growth Stocks as Rising Geopolitical Risk Shakes Markets
Flowserve, California Resources and Globus Medical stand out as sales-growth buys as oil spikes and Iran-Strait tensions shake markets.
California Resources Corporation Schedules First Quarter 2026 Earnings Conference Call
LONG BEACH, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- California Resources Corporation (NYSE: CRC) plans to release its first quarter 2026 financial results on Tuesday, May 5th after market close.
IDEAYA Biosciences Announces First-Patient-In for Phase 1 Trial of IDE574, a Potential First-In Class Dual Inhibitor of KAT6/7 to Target Multiple Solid Tumor Indications, including Breast, Prostate, CRC, and Lung Cancer
Potential first-in-class and selective equipotent dual inhibitor of KAT6/7 with single-digit to low teens nano-molar cellular potency in target engagement assays against KAT6 and KAT7, and ~350-to-2,000-fold selectivity over the KAT5 and KAT8 paralogs KAT6/7 dual inhibitor demonstrates greater monotherapy efficacy and durability than KAT6 selective inhibitors in preclinical CDX and PDX models Multiple combination opportunities with IDE574 and IDEAYA's proprietary pipeline Potential first-in-class and best-in-class preclinical profile will be presented at AACR 2026 SOUTH SAN FRANCISCO, Calif., April 6, 2026 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a leading precision medicine oncology company, today announced that the first patient has been enrolled in its Phase 1 dose escalation trial evaluating IDE574, a potential first-in-class oral small molecule equipotent dual inhibitor of the lysine acetyltransferase (KAT) 6 and 7 paralogs, both of which have been shown to support cancer cell survival.
Allspring Global Investments Holdings LLC Purchases 225,210 Shares of California Resources Corporation $CRC
Allspring Global Investments Holdings LLC boosted its position in California Resources Corporation (NYSE: CRC) by 2,349.1% during the fourth quarter, according to its most recent 13F filing with the SEC. The firm owned 234,797 shares of the oil and gas producer's stock after acquiring an additional 225,210 shares during the period. Allspring Global
Price Targets
California Resources price target lowered to $78 from $82 at UBS
$78.00
(was $59.30)
UBS
California Resources price target raised to $84 from $62 at Jefferies
$84.00
(was $64.74)
Emma Schwartz
·
Jefferies
California Resources price target lowered to $63 from $64 at UBS
$63.00
(was $49.06)
UBS
California Resources price target lowered to $65 from $68 at Barclays
$65.00
(was $48.82)
Barclays
California Resources resumed with an Outperform at RBC Capital
$70.00
(was $46.39)
RBC Capital
California Resources price target lowered to $64 from $68 at UBS
$64.00
(was $48.48)
UBS
California Resources price target raised to $72 from $71 at Mizuho
$72.00
(was $47.11)
Mizuho Securities
California Resources price target lowered to $56 from $58 at Wells Fargo
$56.00
(was $47.26)
Sam Margolin
·
Wells Fargo
California Resources initiated with an Overweight at Wells Fargo
$58.00
(was $47.31)
Sam Margolin
·
Wells Fargo
California Resources price target raised to $71 from $61 at Jefferies
$71.00
(was $55.00)
Emma Schwartz
·
Jefferies
California Resources price target raised to $66 from $60 at Barclays
$66.00
(was $56.81)
Betty Jiang
·
Barclays
California Resources price target raised to $71 from $65 at Mizuho
$71.00
(was $53.01)
Mizuho Securities
Roth suspects California Resources-Berry synergies may be higher than guided
$63.00
(was $53.01)
Leo Mariani
·
Roth Capital
California Resources price target raised to $65 from $64 at Mizuho
$65.00
(was $56.33)
Nitin Kumar
·
Mizuho Securities
California Resources price target raised to $58 from $51 at UBS
$58.00
(was $47.60)
Josh Silverstein
·
UBS
California Resources price target lowered to $47 from $55 at Barclays
$47.00
(was $34.87)
Betty Jiang
·
Barclays
California Resources price target lowered to $55 from $57 at Barclays
$55.00
(was $40.27)
Barclays
Jefferies Starts California Resources (CRC) at Buy
$64.00
(was $52.58)
Michael Schwartz
·
Jefferies
Stephens Starts California Resources (CRC) at Overweight
$73.00
(was $50.41)
Mike Scialla
·
Stephens
UBS Starts California Resources (CRC) at Buy
$68.00
(was $51.03)
Josh Silverstein
·
UBS